Influenza virus neuraminidase — Drug Target

All drugs that target Influenza virus neuraminidase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Neuraminidase inhibitor

Phase 3 pipeline (1)

• Intravenous (IV) zanamivir · GlaxoSmithKline · Neuraminidase inhibitor · Infectious Disease
  Zanamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells by inhibiting the viral neuraminidase enzyme.